NextCure, Inc. (NXTC) Misses Q2 EPS by 9c

NextCure, Inc. (NASDAQ: NXTC) reported Q2 EPS of ($0.64), $0.09 worse than the analyst estimate of ($0.55).

For earnings history and earnings-related data on NextCure, Inc. (NXTC) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Apple’s big price hike seen as "an unprecedented push to protect margins"
• Hyperscale Data acquires 48.5 acres to expand Michigan campus